Supreme Court Hands Bayer Shield as Roundup Suits Ease
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
What First Time Investors Need To Know
Discover key insights every first time investor should know. Equip yourself with the knowledge for a successful and rewarding investing experience.
28,352 articles
Adam Back’s 30,021 Bitcoin Deal Faces Financing Reset
A marquee Bitcoin treasury deal tied to Adam Back’s 30,021 bitcoin is undergoing a financing overhaul as key backers ...
Defense Companies Agree Ramp Output After Trump Meeting
Defense contractors pledged to accelerate production after a White House meeting with top executives and President Tr...
MARA While Bitcoin Falls: AI Pivot Drives Stock Surge
Marathon Digital climbs as Bitcoin slides, buoyed by a strategic pivot into enterprise AI compute infrastructure and ...
NextEra’s Billion Dominion Takeover Creates Largest Utility
NextEra Energy is pursuing a $67 billion all-stock deal to buy Dominion, aiming to create the world’s largest utility...
Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Solana Summer Could Lead the Next Altcoin Rally If Bitcoin Holds
Traders weigh a potential pivot: if Bitcoin holds steady, the crypto scene may spark a 'solana summer' that could lif...
Volkswagen Says Automaker Weighing More Job Cuts Today
Volkswagen signals the possibility of up to 50,000 additional job cuts, potentially bringing total reductions to as m...
Trump Said ‘Economy Roaring’ Yet Jobs Lag and Gas Prices Rise
A new jobs report shows US payrolls fell in February even as energy costs surged and stocks slid, challenging the ide...
Analyst Thinks ASML Worth Nearly $2K on EUV Rally Today
A major brokerage lifts its price target for ASML to near $2,000, citing surging EUV demand from DRAM makers and a sw...
Guggenheim Just Slapped Rating on StubHub: Buy Target at $12.50
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...
Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status